Hongmei Gu
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms 5
- Cancer-related molecular mechanisms research 5
- Molecular Biology top 10%
- RNA modifications and cancer 5
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 13
- Immunology top 10%
- Surgery top 10%
- Cholesterol and Lipid Metabolism 10
- Lipoproteins and Cardiovascular Health 9
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 9
-
- Radiomics and Machine Learning in Medical Imaging 6
- Co-authors
- Dawei ZhangYuh Min ChookMeijing WangRagini VittalElizabeth A. MicklerChunyan HuangXiuhua DongAnindita Biswas
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Hongmei Gu
91 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 124
- Cancer Research 279
- Molecular Biology 964
- Oncology 362
- Immunology 249
- Surgery 458
Countries citing papers authored by Hongmei Gu
This map shows the geographic impact of Hongmei Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongmei Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongmei Gu more than expected).
Fields of papers citing papers by Hongmei Gu
This network shows the impact of papers produced by Hongmei Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongmei Gu. The network helps show where Hongmei Gu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongmei Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 9 | |
| 9 | 2021 | 8 | |
| 10 | 2019 | 27 | |
| 11 | 2019 | 18 | |
| 12 | 2018 | 1 | |
| 13 | IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis | 2017 | 1 |
| 14 | 2017 | 89 | |
| 15 | 2015 | 32 | |
| 16 | 2013 | 7 | |
| 17 | 2013 | 47 | |
| 18 | 2013 | 29 | |
| 19 | 2011 | 19 | |
| 20 | 2011 | 59 |
About Hongmei Gu
Hongmei Gu is a scholar working on Cancer Research, Oncology and Surgery, having authored 96 papers that have together received 2.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (13 papers), Cholesterol and Lipid Metabolism (10 papers), Lipoproteins and Cardiovascular Health (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Radiomics and Machine Learning in Medical Imaging (6 papers), Protease and Inhibitor Mechanisms (5 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Cancer Research (279 citations), Molecular Biology (964 citations) and Oncology (362 citations). Hongmei Gu has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Dawei Zhang, Yuh Min Chook, Meijing Wang, Ragini Vittal, Elizabeth A. Mickler, Chunyan Huang, Xiuhua Dong, Anindita Biswas, Laurie K. Jackson and David S. Wilkes. Their work appears in journals such as Nature, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.